Gil Press
Gil Press
Contributor, The Yuan

Gil Press is Managing Partner at gPress, a marketing, publishing, research and education consultancy and a Senior Contributor at Forbes.com where he writes about technology, entrepreneurs, and innovation. Previously, he was Senior Director of Thought Leadership Marketing at EMC, where he launched the Big Data conversation by commissioning the first studies to quantify the amount of data created worldwide, leading to his current coverage of the latest developments in artificial intelligence. Press started his career implementing a pioneering Point-of-Sale system, managed the first-ever computer-assisted telephone interviewing project, and served as Manager of Corporate Market Analysis at Digital Equipment Corporation.

AI, Quantum Computing Speed Drug Discovery
Optimization
The development of new drugs is a slow, exhaustive, and expensive process that can last over ten years, and often ends in failure. Gil Press investigates the deployment of new AI technologies, techniques, and quantum computing (QC) to transform the procedure to make it faster, easier, and cheaper.
Gil Press,  |  Sep 24, 2021
AI Digital Health Platform Improves Chronic Diseases
Optimization
Digital Health is possibly the most prominent of the technology-driven trends the COVID-19 pandemic has drastically accelerated. The concepts of remote patient monitoring, understanding the social determinants of health, and continuous patient data collection and analysis for early detection, ongoing interaction and intervention, and the use of AI to do all that and more are not novel.
Gil Press,  |  Aug 26, 2021
Healing US Healthcare With AI
Pandemic
As the post-pandemic “new normal” takes hold in the US and the country learns to live with COVID-19, the potential for using AI to address some of the long-term deficiencies of the healthcare system in the US has never been greater. Recent progress in AI capabilities, the lessons learned during the pandemic, and new entrepreneurial endeavors, are coalescing into a renewed focus on providing the right treatment at the right time in the most appropriate setting.
Gil Press,  |  Aug 02, 2021